Reliance Clinical Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
as on 27-12-2024
- Paid Up Capital ₹ 0.10 M
as on 27-12-2024
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 88.71%
(FY 2022)
- Ebitda 90.83%
(FY 2022)
- Net Worth -12.31%
(FY 2022)
- Total Assets -4.98%
(FY 2022)
About Reliance Clinical Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jyotsna Anand and Ajay Anand serve as directors at the Company.
- CIN/LLPIN
U74899DL1992PTC047793
- Company No.
047793
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Reliance Clinical Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyotsna Anand  | Director | 15-Feb-2016 | Current |
| Ajay Anand | Director | 27-Feb-1992 | Current |
Financial Performance of Reliance Clinical Laboratories.
Reliance Clinical Laboratories Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 88.71% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reliance Clinical Laboratories?
In 2022, Reliance Clinical Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ab Diagnopath Manufacturing Private LimitedActive 14 years 7 monthsJyotsna Anand and Ajay Anand are mutual person
A B Diachem Systems Private LimitedActive 35 years 4 monthsJyotsna Anand and Ajay Anand are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reliance Clinical Laboratories?
Unlock and access historical data on people associated with Reliance Clinical Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reliance Clinical Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reliance Clinical Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
